CIK 0001125345 · Non-accelerated filer<br>Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $129,086
- in 1 filing, $129K under 10b5-1 plans
Net −$129,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-08 | Koenig Scott President and CEO | Grant or award | +31,673 | 735,086 | ||
| 2025-02-08 | Koenig Scott President and CEO | Option exercise · Restricted Stock Unit | −31,673 | 63,327 | ||
| 2025-02-08 | Spitznagel Thomas Sr VP, Technical Ops | Option exercise | +9,001 | 17,317 | ||
| 2025-02-08 | Spitznagel Thomas Sr VP, Technical Ops | Shares withheld for taxes | −3,727 | $2.60 | $10K | 13,590 |
| 2025-02-08 | Spitznagel Thomas Sr VP, Technical Ops | Option exercise · Restricted Stock Unit | −9,001 | 17,999 | ||
| 2025-02-08 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise | +9,001 | 9,001 | ||
| 2025-02-08 | Peters Jeffrey Stuart Senior VP and General Counsel | Shares withheld for taxes | −3,475 | $2.60 | $9K | 5,526 |
| 2025-02-08 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise · Restricted Stock Unit | −9,001 | 17,999 | ||
| 2025-02-07 | Eck Stephen L. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +113,000 | 113,000 | ||
| 2025-02-07 | Eck Stephen L. Chief Medical Officer | Grant or award · Restricted Stock Unit | +19,000 | 19,000 | ||
| 2025-02-07 | Bonvini Ezio Sr VP, Research & CSO | Grant or award · Employee Stock Option (right to buy) | +128,000 | 128,000 | ||
| 2025-02-07 | Bonvini Ezio Sr VP, Research & CSO | Grant or award · Restricted Stock Unit | +21,000 | 21,000 | ||
| 2025-02-07 | Risser Eric Blasius Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2025-02-07 | Risser Eric Blasius Chief Operating Officer | Grant or award · Restricted Stock Unit | +20,000 | 20,000 | ||
| 2025-02-07 | Karrels James SVP, CFO and Secretary | Grant or award · Employee Stock Option (right to buy) | +113,000 | 113,000 | ||
| 2025-02-07 | Karrels James SVP, CFO and Secretary | Grant or award · Restricted Stock Unit | +19,000 | 19,000 | ||
| 2025-02-07 | Smith Beth Ann VP, Controller & Treasurer | Grant or award · Employee Stock Option (right to buy) | +47,050 | 47,050 | ||
| 2025-02-07 | Smith Beth Ann VP, Controller & Treasurer | Grant or award · Restricted Stock Unit | +7,850 | 7,850 | ||
| 2025-02-07 | Spitznagel Thomas Sr VP, Technical Ops | Grant or award · Employee Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2025-02-07 | Spitznagel Thomas Sr VP, Technical Ops | Grant or award · Restricted Stock Unit | +18,000 | 18,000 |
Page 11 of 17 · 322 trades